Cite
MLA Citation
Jorge E. Cortes et al.. “Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results.” American journal of hematology, vol. 93, no. 11, n.d., pp. 1301–1310. http://access.bl.uk/ark:/81055/vdc_100070816656.0x00003b